Roberto Della Casa

A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy

Giancarlo Parenti, Simona Fecarotta, Giancarlo la Marca et al. · Molecular Therapy · 2014 · 89 citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +17

Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy

Rossella Parini, Paola De Lorenzo, Andrea Dardis et al. · Orphanet Journal of Rare Diseases · 2018 · 89 citations · Full text

Medicine, Immunology, Pediatrics +11

Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C

Simona Fecarotta, Alfonso Romano, Roberto Della Casa et al. · Orphanet Journal of Rare Diseases · 2015 · 63 citations · Full text

Medicine, Neurology, Pediatrics +11

Long-Term Enzyme Replacement Therapy for Pompe Disease With Recombinant Human Alpha-glucosidase Derived From Chinese Hamster Ovary Cells

Massimiliano Rossi, Giancarlo Parenti, Roberto Della Casa et al. · Journal of Child Neurology · 2007 · 56 citations

Life Sciences, Biochemistry, Cardiology +16

The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann–Pick disease type C after therapy with miglustat

Simona Fecarotta, Michele Amitrano, Alfonso Romano et al. · American Journal of Medical Genetics Part A · 2011 · 38 citations

Health Professions, Neurology, Pediatrics +17